For press inquiries click here to contact us.
Alumis, Inc.
AAD25: Ahead of Acelyrin merger, Alumis flexes mid-stage data for oral TYK2 inhibitor in psoriasis
Genomics PLC
Bupa to offer first genetic test for disease prediction in UK
Avenzo Therapeutics
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio
Element Biosciences
Element Biosciences AVITI Sequencing
Xaira Therapeutics
Eye On AI: Funding To Biotech And Healthcare Startups Using AI Takes Off After Dip In 2023
Sollis Health
Sollis Health: Concierge Medicine Provider Company Secures $33 Million (Series B)
Foresight Diagnostics
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
Relay Therapeutics
Top Story Relay zeroes in on breast cancer subgroup for pivotal PI3Kα inhibitor study
Element Biosciences
How Element Biosciences pushes the boundary of innovation
Please see important disclaimers in the Terms section.
